Picture of Vericel logo

VCEL — Vericel News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Vericel Corp reports results for the quarter ended in March - Earnings Summary

* Vericel Corp  VCEL.OQ  reported a quarterly adjusted loss
of 16
cents​​ per share for the quarter ended in March. The mean
expectation of five analysts for the quarter was for a loss
of 15 cents per share.
    * Revenue rose 13.7% to $41.02 million from a year ago;
analysts
expected $37.87 million. 
    * Vericel Corp's reported EPS for the quarter was a loss
of 16
cents​.
    * The mean earnings estimate of analysts had fallen by
about 14.3%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Vericel Corp shares had risen by 12.0% this quarter and
gained 24.7% so far this year.
    * The company reported a quarterly loss of $7.5 million.
    * Wall Street's median 12-month price target for Vericel
Corp is
$38.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
10 at 01:32 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.15          -0.16          Missed
 Dec. 31 2022      0.04           0.12           Beat
 Sep. 30 2022      -0.10          -0.14          Missed
 Jun. 30 2022      -0.12          -0.19          Missed

Recent news on Vericel

See all news